🔥36氪•Stalecollected in 32m
OYMotion Secures 150M CNY C-Round
#neurotech#embodied-ai#funding#roboticsrohand-dexterous-handsoymotionrohandorfzhongjin-brain-science
💡Neurotech funding boom: OYMotion's 5x robot hand sales as BCI policy surges
⚡ 30-Second TL;DR
What Changed
150M CNY C-round led by Zhongjin Brain Science Fund with follow-on from existing investors
Why It Matters
Funding accelerates OYMotion's expansion in BCI and embodied AI amid China policy push. Overseas dominance highlights global neurotech demand, positioning it as key supplier for humanoid robotics.
What To Do Next
Evaluate ROHand dexterous hands for integration into humanoid robot prototypes.
Who should care:Developers & AI Engineers
Key Points
- •150M CNY C-round led by Zhongjin Brain Science Fund with follow-on from existing investors
- •ROHand dexterous hands achieve 5x shipment growth to nearly 100 humanoid robot customers
- •Overseas revenue and volume surpass domestic across Europe, US, Middle East, SE Asia
- •'Brain-EEG, Muscle-EMG, Machine-Robot' path enables scalable neuro-rehab solutions
- •Products deployed in top hospitals and leading humanoid robot makers
🧠 Deep Insight
AI-generated analysis for this event.
🔑 Enhanced Key Takeaways
- •OYMotion's core technology leverages proprietary high-density surface electromyography (sEMG) sensors that utilize dry electrode technology, eliminating the need for conductive gels and enabling rapid, repeatable clinical application.
- •The company has strategically pivoted from its origins in medical rehabilitation devices to become a critical component supplier for the humanoid robotics industry, specifically focusing on the 'human-in-the-loop' control interface for dexterous manipulation.
- •The C-round capital is earmarked for the construction of a new automated production facility in the Yangtze River Delta to meet the scaling demands of international humanoid robot OEMs, aiming to reduce unit costs by 40% through manufacturing efficiencies.
📊 Competitor Analysis▸ Show
| Feature | OYMotion (ROHand) | Delsys (Trigno) | Myomo (MyoPro) |
|---|---|---|---|
| Primary Market | Humanoid Robotics / Rehab | Research / Clinical EMG | Medical Rehab Exoskeletons |
| Sensor Tech | Dry sEMG / AI Parsing | High-fidelity Wireless EMG | EMG-driven Orthotics |
| Integration | Native ROS/ROS2 support | Research-focused SDK | Proprietary closed system |
| Pricing | Mid-range (OEM focused) | High (Research grade) | High (Clinical/Insurance) |
🛠️ Technical Deep Dive
- Sensor Fusion Architecture: Employs a multi-modal approach integrating sEMG (surface electromyography) and EEG (electroencephalography) data streams processed through a lightweight, edge-deployed neural network.
- Signal Processing: Utilizes a proprietary 'Neuro-Parsing' algorithm that performs real-time signal denoising and motion intent decoding with a latency of <20ms, critical for real-time robotic control.
- Dexterous Hand Control: The ROHand series utilizes a distributed control architecture where local sensor nodes communicate via CAN-FD bus, allowing for high-bandwidth feedback loops between the sensor array and the robotic actuators.
- Dry Electrode Material: Uses a conductive polymer composite that maintains signal integrity across varying skin impedance levels, reducing the need for skin preparation.
🔮 Future ImplicationsAI analysis grounded in cited sources
OYMotion will achieve a dominant market share in the humanoid robot sensor component sector by 2027.
The company's current rapid expansion into international OEM supply chains suggests a scalable business model that outpaces traditional medical-only competitors.
The company will release a consumer-grade wearable interface for non-robotic digital interaction.
The shift toward high-volume manufacturing and the maturity of their EMG-parsing AI suggests a transition from specialized robotics to broader human-computer interaction (HCI) applications.
⏳ Timeline
2015-05
OYMotion founded in Shanghai, focusing on EMG sensor technology for rehabilitation.
2018-09
Released first-generation wearable EMG gesture control armband for research and education.
2021-11
Secured B-round funding to expand R&D into robotic-integrated sensor systems.
2023-06
Launched the ROHand series, marking the company's formal entry into the humanoid robot component market.
2026-03
Completed 150M CNY C-round funding led by Zhongjin Brain Science Fund.
📰
Weekly AI Recap
Read this week's curated digest of top AI events →
👉Related Updates
AI-curated news aggregator. All content rights belong to original publishers.
Original source: 36氪 ↗